SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001193125-10-044937
Filing Date
2010-03-01
Accepted
2010-03-01 17:27:05
Documents
6
Group Members
ASTELLAS US HOLDING, INC.RUBY ACQUISITION, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE TO-C dsctoc.htm SC TO-C 152712
2 GRAPHIC g52437tx_pg002.jpg GRAPHIC 23943
3 GRAPHIC g52437tx_pg013a.jpg GRAPHIC 408
4 GRAPHIC g52437tx_pg013b.jpg GRAPHIC 408
5 GRAPHIC g52437tx_pg022a.jpg GRAPHIC 4390
6 GRAPHIC g52437tx_pg022b.jpg GRAPHIC 5144
  Complete submission text file 0001193125-10-044937.txt   202752
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-37954 | Film No.: 10646340
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411
Business Address 3-11 NIHONBASHI-HONCHO 2-CHOME CHUO-KU TOKYO M0 103-8411 81-3-3244-3231
Astellas Pharma Inc. (Filed by) CIK: 0001376684 (see all company filings)

IRS No.: 132971791
Type: SC TO-C